Author

Ramona Vladea 1

1 AbbVie Inc., North Chicago, United States

BENEFIT–RISK ASSESSMENT OF UPADACITINIB TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Remo Panaccione, Irina Blumenstein, Peter Irving, Ramona Vladea, Dapo Ilo, Wen Zhou, Gweneth Levy, Xuan Yao, Iris Dotan

Item 1 - 1 / 1
1